These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27957216)

  • 1. Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.
    Barman M
    J Atr Fibrillation; 2015 Dec; 8(4):1091. PubMed ID: 27957216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
    Falk RH
    Ann Intern Med; 1989 Jul; 111(2):107-11. PubMed ID: 2500880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation.
    Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV
    Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.
    Camm AJ; Hellestrand KJ; Nathan AW; Bexton RS
    Drugs; 1985; 29 Suppl 4():7-13. PubMed ID: 4006783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination.
    Biffi M; Boriani G; Bronzetti G; Capucci A; Branzi A; Magnani B
    Heart; 1999 Aug; 82(2):176-82. PubMed ID: 10409531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
    Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
    Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
    Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.
    Hellestrand KJ; Bexton RS; Nathan AW; Spurrell RA; Camm AJ
    Br Heart J; 1982 Aug; 48(2):140-8. PubMed ID: 7093083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of exercise-induced and spontaneous wide complex tachycardia during therapy with flecainide for complex ventricular arrhythmias: a probable proarrhythmic effect.
    Anastasiou-Nana MI; Anderson JL; Stewart JR; Crevey BJ; Yanowitz FG; Lutz JR; Johnson TA
    Am Heart J; 1987 May; 113(5):1071-7. PubMed ID: 3107362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide in clinical practice.
    Basza M; Maciejewski C; Bojanowicz W; Balsam P; Grabowski M; Mitkowski P; Kempa M; Kowalski O; Kalarus Z; Jaguszewski M; Lubiński A; Daniłowicz-Szymanowicz L; Szumowski Ł; Sterliński M; Kołtowski Ł
    Cardiol J; 2023; 30(3):473-482. PubMed ID: 36908162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.